Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting

A cross-sectional study was conducted to predict time in therapeutic range (TTR) using clinical history, examination, and socioeconomic data. Study included warfarin-receiving patients from outpatient-clinic. In 203 patients studied, mean warfarin start-dose was 2.55 mg/day and maintenance-dose/week...

Full description

Bibliographic Details
Main Authors: Aishwarya Anand, Rupesh Kumar, Ankur Gupta, Rajesh Vijayvergiya, Saurabh Mehrotra, Deepesh Lad, Parag Barwad, Swati Sharma, Amol N. Patil
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483222000529
_version_ 1818217051292958720
author Aishwarya Anand
Rupesh Kumar
Ankur Gupta
Rajesh Vijayvergiya
Saurabh Mehrotra
Deepesh Lad
Parag Barwad
Swati Sharma
Amol N. Patil
author_facet Aishwarya Anand
Rupesh Kumar
Ankur Gupta
Rajesh Vijayvergiya
Saurabh Mehrotra
Deepesh Lad
Parag Barwad
Swati Sharma
Amol N. Patil
author_sort Aishwarya Anand
collection DOAJ
description A cross-sectional study was conducted to predict time in therapeutic range (TTR) using clinical history, examination, and socioeconomic data. Study included warfarin-receiving patients from outpatient-clinic. In 203 patients studied, mean warfarin start-dose was 2.55 mg/day and maintenance-dose/week was 30.79 mg. Body mass index (BMI) (p = 0.03), warfarin maintenance dose/day (p = 0.02), and comorbidity presence (p = 0.04) were significantly associated with TTR. Occupation (p = 0.53), income (p = 0.83), education (p = 0.55), and socioeconomic score (p = 0.73) showed non-significant association with TTR. A TTR predicting nomogram was built from clinical history and examination findings.
first_indexed 2024-12-12T07:01:43Z
format Article
id doaj.art-2316312ed2344235a2c3046633a28ba1
institution Directory Open Access Journal
issn 0019-4832
language English
last_indexed 2024-12-12T07:01:43Z
publishDate 2022-05-01
publisher Elsevier
record_format Article
series Indian Heart Journal
spelling doaj.art-2316312ed2344235a2c3046633a28ba12022-12-22T00:33:50ZengElsevierIndian Heart Journal0019-48322022-05-01743245248Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource settingAishwarya Anand0Rupesh Kumar1Ankur Gupta2Rajesh Vijayvergiya3Saurabh Mehrotra4Deepesh Lad5Parag Barwad6Swati Sharma7Amol N. Patil8Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Cardiothoracic and Vascular Surgery, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; Co-Corresponding author. Department of Cardiology, PGIMER, Chandigarh, India.Department of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; Corresponding author. Department of Pharmacology, PGIMER, Chandigarh, 160012, India.A cross-sectional study was conducted to predict time in therapeutic range (TTR) using clinical history, examination, and socioeconomic data. Study included warfarin-receiving patients from outpatient-clinic. In 203 patients studied, mean warfarin start-dose was 2.55 mg/day and maintenance-dose/week was 30.79 mg. Body mass index (BMI) (p = 0.03), warfarin maintenance dose/day (p = 0.02), and comorbidity presence (p = 0.04) were significantly associated with TTR. Occupation (p = 0.53), income (p = 0.83), education (p = 0.55), and socioeconomic score (p = 0.73) showed non-significant association with TTR. A TTR predicting nomogram was built from clinical history and examination findings.http://www.sciencedirect.com/science/article/pii/S0019483222000529Warfarin nomogramPercent time in therapeutic rangeINR
spellingShingle Aishwarya Anand
Rupesh Kumar
Ankur Gupta
Rajesh Vijayvergiya
Saurabh Mehrotra
Deepesh Lad
Parag Barwad
Swati Sharma
Amol N. Patil
Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
Indian Heart Journal
Warfarin nomogram
Percent time in therapeutic range
INR
title Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
title_full Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
title_fullStr Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
title_full_unstemmed Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
title_short Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
title_sort development of an interview based warfarin nomogram predicting the time spent in the therapeutic inr range a cost effective and non invasive strategy building from a cross sectional study in a low resource setting
topic Warfarin nomogram
Percent time in therapeutic range
INR
url http://www.sciencedirect.com/science/article/pii/S0019483222000529
work_keys_str_mv AT aishwaryaanand developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT rupeshkumar developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT ankurgupta developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT rajeshvijayvergiya developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT saurabhmehrotra developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT deepeshlad developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT paragbarwad developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT swatisharma developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting
AT amolnpatil developmentofaninterviewbasedwarfarinnomogrampredictingthetimespentinthetherapeuticinrrangeacosteffectiveandnoninvasivestrategybuildingfromacrosssectionalstudyinalowresourcesetting